`ESTTA1075731
`08/18/2020
`
`ESTTA Tracking number:
`
`Filing date:
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Application Serial
`No.
`
`88418271
`
`Applicant
`
`CRANBURY PHARMACEUTICALS
`
`Notice of Appeal
`
`Notice is hereby given that CRANBURY PHARMACEUTICALS appeals to the Trademark Trial and Appeal
`Board the refusal to register the mark depicted in Application Serial No. 88418271.
`Applicant has filed a request for reconsideration of the refusal to register, and requests suspension of the ap-
`peal pending consideration of the request by the Examining Attorney.
`
`The refusal to register has been appealed as to the following class of goods/services:
`- Class 005. First Use: 0 First Use In Commerce: 0
`All goods and services in the class are appealed, namely: Prescription and non-prescription pharmaceutic-
`al medicines and preparations forthe treatment of cold and allergy symptoms, respiratory disease, asthma
`and chronic lung disease, upper respiratory symptoms, coughs, central nervous system disorders,
`namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia,
`bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief,
`and for anti-inflammation; dietary supplements; nutritional supplements; vitamins; nutritional supplements
`in the nature of nutriceuticals for use in treating nutritional deficiencies and as dietary supplements
`Respectfully submitted,
`/CathyAKodroff/
`08/18/2020
`CATHY KODROFF
`HOWSON & HOWSON LLP
`325 SENTRY PARKWAY EAST
`FIVE SENTRY EAST, STE 160
`BLUE BELL, PA 19422
`UNITED STATES
`Primary Email: docketing@howsoniplaw.com
`Secondary Email(s): ckodroff@howsoniplaw.com
`215-540-9210
`
`Docket Number
`
`TRIS-CBP
`
`